AP-30663

N/A

Report date: 2024/03/22 16:54:48
NME

Base Information

Drug NameAP-30663
Drug Alias NameAP-30663
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSmall conductance calcium-activated potassium channel protein 1 inhibitors
TargetsSmall conductance calcium-activated potassium channel protein 1
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungaryDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcesion Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAcesion Pharma
Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A